JPRN-UMIN000035776已完成未知
A study to examine the effects of Lactobacillus salivarius L55 intake on relief from eye and nasal discomfort. - A study to examine the effects of Lactobacillus salivarius L55 intake on relief from eye and nasal discomfort.
IMEQRD Co., Ltd0 个研究点目标入组 50 人开始时间: 2019年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Those who were categized into "severe" or "the most severe" according to the classification of allergic rhinitis based on severity of symptoms. 2. Those who have acute rhinitis, sinusitis, nasal polyp, hypertrophic rhinitis, and deviated septum. 3. Those who have bronchial asthma as a complication. 4. Those who have the serious disorders of the liver, heart, kidney, respiratory system, endocrine, and metabolism. 5. Those who currently receive or have previously received allergen immunotherapy. 6. Those who currently take some kind of medication for therapeutic purposes. 7. Those with a past and current medical history of drug or food allergy. 8. Those who ingest Lactobacillus preparations, Lactobacillus supplements, yogurts, foods for specified health use, and foods with function claims on a daily basis (however, at the time of submission of an informed consent document, those who can stop ingesting foods listed above during the study period are excluded). 9. Those who are currently pregnant or breastfeeding or those who desire a pregnancy during the study period. 10. Those who have experienced a feeling sick or health deterioration due to blood sampling. 11. Those who have diarrhea by dairy products and those who have lactose intolerance. 12. Those who participated in another clinical trial within one month before our screening test and those who took an active ingredient provided in the clinical trial. 13. Those who may undergo lifestyle changes (such as a long trip) during the study period. 14. Those who were determined by the principal investigator to be unsuitable for participation in this clinical trial.
研究者
相似试验
已完成
不适用
Effectiveness of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitisDiseases of the skin and subcutaneous tissueKCT0001288Samsung Medical Center100
终止
不适用
Investigation of WCFS1 on the gut microbiota of autistic spectrum disorder (ASD) childreISRCTN04516575niversity of Reading (UK)70
招募中
不适用
Evaluation of the effect of Lactobacillus preparation EBC-031206healthy adultsJPRN-UMIN000008800Faculty of Dentistry Tokushima University30
已完成
不适用
Study of the effect of Lactobacillus LB product on healthy volunteers' fecal microbiota compositioNL-OMON48365IZO food research30
尚未招募
3 期
Evaluation of the effect of Lactobacillus reuteri probiotic in functional constipatioConstipationfunctional constipation in children.K59.0IRCT20150706023084N13Faradaro Fanavar Mehr Company160